PET/SPECT/MRI/fMRI Studies in the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, 2020, Watanabe

https://link.springer.com/chapter/10.1007/978-3-030-57231-0_32

PET/SPECT/MRI/fMRI Studies in the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

• Yasuyoshi Watanabe

• Chapter
• First Online: 15 December 2020

• 
  547 Accesses
  
  
• 3 Citations

Abstract
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a serious, debilitating disorder with a wide spectrum of symptoms, including fatigue, pain, depression and neurocognitive deterioration. Over 17 million people around the world have ME/CFS, predominantly women with peak onset at 30–50 years. Given the wide spectrum of symptoms and unclear etiology, specific biomarkers for diagnosis and stratification of ME/CFS are lacking. Here the results from PET/SPECT/MRI/fMRI studies are reviewed to understand the pathophysiology and to develop therapies of this severe syndrome.

Keywords

• Myalgic encephalomyelytis/chronic fatigue syndrome
• Brain morphometry
• Connectivity
• Regional cerebral blood flow
• Glucose utilization rate
• Serotonergic deterioration
• Neuroinflammation
• Repair energy loss

---

I've heard it's available here: https://sci-hub.se/

 

Thanks for posting @Dolphin